BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Klieser E, Swierczynski S, Mayr C, Schmidt J, Neureiter D, Kiesslich T, Illig R. Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy. World J Gastrointest Oncol 2015; 7(12): 473-483 [PMID: 26691388 DOI: 10.4251/wjgo.v7.i12.473]
URL: https://www.wjgnet.com/1948-5204/full/v7/i12/473.htm
Number Citing Articles
1
Othman Saleh, Hani Shihadeh, Ahmad Yousef, Hana Erekat, Fatima Abdallh, Ahmad Al-leimon, Rawan Elsalhy, Abdalrahman Altiti, Majd Dajani, Majd M. AlBarakat. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and TreatmentPancreas 2024; 53(5): e450 doi: 10.1097/MPA.0000000000002342
2
Bingyi Zhou, Deliang Liu, Yuyong Tan. Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.719390
3
Max M. Träger, Sameer A. Dhayat. Epigenetics of epithelial‐to‐mesenchymal transition in pancreatic carcinomaInternational Journal of Cancer 2017; 141(1): 24 doi: 10.1002/ijc.30626
4
Chandra Maharjan, Po Ear, Catherine Tran, James Howe, Chandrikha Chandrasekharan, Dawn Quelle. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic TargetsCancers 2021; 13(20): 5117 doi: 10.3390/cancers13205117
5
Xue-Song Xiang, Peng-Cheng Li, Wen-Quan Wang, Liang Liu. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188676 doi: 10.1016/j.bbcan.2022.188676
6
Eckhard Klieser, Romana Urbas, Stefan Stättner, Florian Primavesi, Tarkan Jäger, Adam Dinnewitzer, Christian Mayr, Tobias Kiesslich, Klaus Holzmann, Pietro Di Fazio, Daniel Neureiter, Stefan Swierczynski. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcomeHuman Pathology 2017; 65: 41 doi: 10.1016/j.humpath.2017.02.009
7
M. Borghesani, L. Gervaso, C.A. Cella, L. Benini, D. Ciardiello, L. Algeri, A. Ferrero, C. Valenza, L. Guidi, MG. Zampino, F. Spada, N. Fazio. Promising targetable biomarkers in pancreatic neuroendocrine tumoursExpert Review of Endocrinology & Metabolism 2023; 18(5): 387 doi: 10.1080/17446651.2023.2248239
8
Fataneh Karandish, James Froberg, Pawel Borowicz, John C. Wilkinson, Yongki Choi, Sanku Mallik. Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumorsColloids and Surfaces B: Biointerfaces 2018; 163: 225 doi: 10.1016/j.colsurfb.2017.12.036
9
Alexander Arlt, Heiner Schäfer. Investigational histone deacetylase inhibitors for treating pancreatic adenocarcinomaExpert Opinion on Investigational Drugs 2016; 25(11): 1251 doi: 10.1080/13543784.2016.1240167
10
Magdalena Mizerska-Kowalska, Adrianna Sławińska-Brych, Emilia Niedziela, Viktor Brodovskiy, Barbara Zdzisińska. Alpha Ketoglutarate Downregulates the Neutral Endopeptidase and Enhances the Growth Inhibitory Activity of Thiorphan in Highly Aggressive Osteosarcoma CellsMolecules 2022; 28(1): 97 doi: 10.3390/molecules28010097
11
Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi, Fatemeh Elahian, Seyed Abbas Mirzaei. Epigenetic Disruption of Histone Deacetylase-2 Accelerated Apoptotic Signaling and Retarded Malignancy in Gastric CellsEpigenomics 2024; 16(5): 277 doi: 10.2217/epi-2023-0350
12
Claudia Geismann, Alexander Arlt. Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic CancerCells 2020; 9(11): 2353 doi: 10.3390/cells9112353
13
Sashikanta Swain, Ravi Kant Narayan, Pravash Ranjan Mishra. Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesisFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1461278
14
Pritha Bhattacharjee, Somnath Paul, Sandip Bhattacharjee, Ashok K. Giri, Pritha Bhattacharjee. Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesionsMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2018; 807: 1 doi: 10.1016/j.mrfmmm.2017.11.001
15
Eckhard Klieser, Romana Urbas, Stefan Swierczynski, Stefan Stättner, Florian Primavesi, Tarkan Jäger, Christian Mayr, Tobias Kiesslich, Pietro Di Fazio, Katharina Helm, Daniel Neureiter. HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine TumorsInternational Journal of Molecular Sciences 2018; 19(9): 2781 doi: 10.3390/ijms19092781
16
Shelby M. Knoche, Gabrielle L. Brumfield, Benjamin T. Goetz, Bailee H. Sliker, Alaina C. Larson, Madeline T. Olson, Brittany J. Poelaert, Audrey Bavari, Ying Yan, Jennifer D. Black, Joyce C. Solheim, Ajay Pratap Singh. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancerPLOS ONE 2022; 17(9): e0273518 doi: 10.1371/journal.pone.0273518
17
Asmaa Elrakaybi, Dietrich A. Ruess, Michael Lübbert, Michael Quante, Heiko Becker. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and TreatmentCancers 2022; 14(23): 5926 doi: 10.3390/cancers14235926
18
Richard S. Laschanzky, Lisa E. Humphrey, Jihyun Ma, Lynette M. Smith, Thomas J. Enke, Surendra K. Shukla, Aneesha Dasgupta, Pankaj K. Singh, Gillian M. Howell, Michael G. Brattain, Quan P. Ly, Adrian R. Black, Jennifer D. Black. Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer TherapyCancers 2019; 11(9): 1327 doi: 10.3390/cancers11091327
19
Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia de Castro Martinez, Adoración Romero-Bazán, Miguel A. Alvarez-Mon, Jorge Monserrat, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Luis G. Guijarro, Miguel A. Ortega. Clinical Applications of Classical and Novel Biological Markers of Pancreatic CancerCancers 2022; 14(8): 1866 doi: 10.3390/cancers14081866
20
Judy S. Crabtree. Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine TumorsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.901435
21
Chiara Deiana, Margherita Agostini, Giovanni Brandi, Elisa Giovannetti. The trend toward more target therapy in pancreatic ductal adenocarcinomaExpert Review of Anticancer Therapy 2024; 24(7): 525 doi: 10.1080/14737140.2024.2357802
22
Sathish Kumar Mungamuri. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy2019; : 133 doi: 10.1016/B978-0-12-817661-0.00009-3
23
Somayeh Layeghi-Ghalehsoukhteh, Shreoshi Pal Choudhuri, Ozhan Ocal, Yalda Zolghadri, Victor Pashkov, Hanspeter Niederstrasser, Bruce A. Posner, Havish S. Kantheti, Ana C. Azevedo-Pouly, Huocong Huang, Luc Girard, Raymond J. MacDonald, Rolf A. Brekken, Thomas M. Wilkie. Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeuticsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77373-8
24
Mao-Hua Cai, Xiao-Gang Xu, Shi-Li Yan, Ze Sun, Yin Ying, Bai-Kui Wang, Yue-Xing Tu. Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with GemcitabineScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20004-0
25
Feda H. Hamdan, Steven A. Johnsen. Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic CancerEpigenomes 2018; 2(2): 8 doi: 10.3390/epigenomes2020008
26
Hong Xiang, Hao Yu, Qi Zhou, Yu Wu, Jiaqi Ren, Zirui Zhao, Xufeng Tao, Deshi Dong. Macrophages: A rising star in immunotherapy for chronic pancreatitisPharmacological Research 2022; 185: 106508 doi: 10.1016/j.phrs.2022.106508
27
Pranita Atri, Ashu Shah, Gopalakrishnan Natarajan, Satyanarayana Rachagani, Sanchita Rauth, Koelina Ganguly, Joseph Carmicheal, Dario Ghersi, Jesse L. Cox, Lynette M. Smith, Maneesh Jain, Sushil Kumar, Moorthy P. Ponnusamy, Parthasarathy Seshacharyulu, Surinder K. Batra. Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinomanpj Precision Oncology 2024; 8(1) doi: 10.1038/s41698-024-00562-5
28
Monika Rola, Jacek Zielonka, Renata Smulik-Izydorczyk, Jakub Pięta, Karolina Pierzchała, Adam Sikora, Radosław Michalski. Boronate-based bioactive compounds activated by peroxynitrite and hydrogen peroxideRedox Biochemistry and Chemistry 2024; 10: 100040 doi: 10.1016/j.rbc.2024.100040